Application

18514269 · Anti-Sclerostin Antibodies and Their Use to Treat Bone Disorders as Part of a Regimen

Filed 2023-11-20 · Granted The official file ↗ · Art unit 1674 · Examiner Xiaozhen Xie Typical · CPC C07K 16/22 · UCB PHARMA S.A. · Marshall, Gerstein & Borun LLP/UCB

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

25.7 mo

to disposition 33.9 mo

Statutes raised

102 103 112 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.